FOXO4-DRI dosage The dominant search intent for "foxo4 dri peptide" is informational, focusing on understanding what the peptide is, how it works, its potential benefits, and its applications, particularly in the context of aging and cellular senescenceSenolytic Peptide FOXO4-DRI Selectively Removes ....
Tier 1:
* Core Entity: FOXO4-DRI peptide
* Key Concepts: Senolytic, cellular senescence, aging, apoptosis, p53 interaction, FOXO4, peptide antagonist, research peptide, zombie cells.
* High-Relevance Phrases: foxo4 dri peptide, senolytic peptide, cellular senescence, healthy aging, induces apoptosis, blocks interaction of FOXO4 and p53.FOXO4-DRI - Drug Targets, Indications, Patents - Synapse
Tier 2:
* Related Entities/Concepts: D-retro-inverso, cell-permeable, cell-penetrating, testosterone secretion, spermatogenesis, chemotoxicity, tissue regeneration, hormonal restoration.FOX04-DRI (10mg Vial) Dosage Protocol
* Attributes/Variations: Synthetic peptide, all D-enantiomer, retro-inverso, investigational peptide, research peptide.
* Applications/Effects: Removes senescent cells, alleviates age-related insufficiency, improves testicular microenvironment, reverses chemotoxicity, targets senescent cells.FOXO4-DRI
Tier 3:
* Less relevant/repetitive: Specific chemical details (molecular weight, amino acid sequence unless contextually important), commercial product names or specific sellers, overly technical jargon without explanation, phrases about search behaviorSenolytic Peptide FOXO4-DRI Selectively Removes ....
---
The FOXO4-DRI peptide is a specialized research compound designed to target and eliminate senescent cells, often referred to as "zombie cells.2017年6月1日—FOXO4-DRI reversed doxorubicin-induced chemotoxicity, including increasing body weight and reducing levels of the liver damage indicator aspartate ..." As a senolytic peptide, FOXO4-DRI plays a crucial role in research focused on healthy aging and the mitigation of age-related decline. Its mechanism involves blocking the interaction between the FOXO4 protein and p53, a key process that can lead to programmed cell death, or apoptosis, in senescent cells. This targeted approach holds significant promise for understanding and potentially intervening in various age-associated conditions.作者：MP Baar·2017·被引用次数：1582—We designed aFOXO4 peptidewhich perturbs the FOXO4 interaction with p53. In senescent cells, this selectively causes p53 nuclear exclusion and cell-intrinsic ...
Cellular senescence is a state where cells stop dividing due to damage or stress but do not die. Instead, they accumulate in tissues, releasing inflammatory factors and contributing to the aging process and a range of diseases. These senescent cells, or "zombie cells," disrupt tissue function and promote inflammation.FOXO4-DRI: A scientific look at the peptide that fights aging ...
The FOXO4-DRI peptide is engineered to specifically disrupt the interaction between FOXO4 and p53 within these senescent cells.FOXO4-DRI - Senolytic Peptide for Targeted Cell Clearance This disruption is critical because the FOXO4-p53 complex is often involved in maintaining the senescent state. By blocking this interaction, FOXO4-DRI can trigger apoptosis, effectively removing these harmful cells from the body.Senolytic Peptide FOXO4-DRI Selectively Removes ... This action positions it as a potent agent in senolytic research, aiming to clear out cellular debris that contributes to aging.
FOXO4-DRI's primary function as a cell-permeable peptide antagonist allows it to easily enter cells and exert its effects.产品详情 · 产品名称.FOXO4D-Retro-Inverso(DRI)多肽 · 序列. H-LTLRKEPASEIAQSILEAYSQNGWANRRSGGKRPPPRRRQRRKKRG-OH · 三字母序列 · 长度(aa) · 多肽纯度(HPLC, %) · 分子式. Its design as a D-retro-inverso peptide means it's composed of non-natural amino acids, which can enhance its stability and resistance to degradation within the body.
Research into FOXO4-DRI has highlighted several potential benefits:
* Targeted Cell Clearance: Its ability to selectively induce apoptosis in senescent cells is its most significant attribute. This means it can remove aged or damaged cells without broadly affecting healthy, functional cells.
* Alleviating Age-Related Issues: Studies, particularly in animal models, have shown that FOXO4-DRI can improve conditions associated with agingIn naturally aged mice,FOXO4-DRI improved the testicular microenvironmentand alleviated age-related testosterone secretion insufficiency.. For instance, it has been observed to alleviate age-related testosterone secretion insufficiency by improving the testicular microenvironment in aged miceFOXO4-DRI peptide.
* Reversing Chemotoxicity: In some research contexts, FOXO4-DRI has demonstrated the capacity to reverse toxicity induced by certain chemotherapy drugs, suggesting a potential role in supportive care during cancer treatment.
* Promoting Tissue Regeneration: By clearing senescent cells that may impede repair processes, FOXO4-DRI could indirectly support tissue regeneration and the restoration of natural hormonal functions, contributing to overall vitalityFOXO4-DRI是一种细胞渗透性肽拮抗剂，可阻断FOXO4 和p53 的相互作用。FOXO4-DRI是一种抗衰老多肽，可诱导衰老细胞凋亡(apoptosis)。- 高纯度，全球文献引用。.
It is important to note that FOXO4-DRI is largely an investigational peptide. While research is promising, it is primarily used in laboratory settings and preclinical studies to explore its therapeutic potential.FOXO4-DRI is an investigational peptide studied for its potential role in healthy aging. By targeting cellular senescence, often called “zombie cells”, it may ... Its precise applications, optimal dosages, and long-term effects in humans are still subjects of ongoing scientific investigation.2025年6月6日—基本信息 · 英文名称：FOXO4-DRI PeptideAcetate · 中文名称：FOXO4 结构域相互作用肽乙酸盐 · 氨基酸序列： · 分子量：约 1424.7 Da（含乙酸盐，Acetate 形式）. The development of senolytic therapies like FOXO4-DRI represents a significant frontier in aging research, aiming to reduce the burden of senescent cells and improve healthspan. As research progresses, the understanding of its full capabilities and potential clinical applications will undoubtedly expandFOXO4-DRI.
Join the newsletter to receive news, updates, new products and freebies in your inbox.